Indomethacin-Enhanced Anticancer Effect of Arsenic Trioxide in A549 Cell Line: Involvement of Apoptosis and Phospho-ERK and p38 MAPK Pathways
Background. Focusing on novel drug combinations that target different pathways especially apoptosis and MAPK could be a rationale for combination therapy in successful treatment of lung cancer. Concurrent use of cyclooxygenase (COX) inhibitors with arsenic trioxide (ATO) might be a possible treatmen...
Main Authors: | Ali Mandegary, Maryam Torshabi, Mohammad Seyedabadi, Bagher Amirheidari, Elham Sharif, Mohammad Hossein Ghahremani |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/237543 |
Similar Items
-
The Roles of p38 MAPK and SUMOs in Arsenic Trioxide-induced Apoptosis
by: Te-Chung Chen, et al.
Published: (2013) -
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1
by: Sunbin Ling, et al.
Published: (2017-02-01) -
Expression of cyclin A in A549 cell line after treatment with arsenic trioxide
by: Agnieszka Żuryń, et al.
Published: (2015-12-01) -
Cyclooxygenase inhibitors combined with deuterium-enriched water augment cytotoxicity in A549 lung cancer cell line via activation of apoptosis and MAPK pathways
by: Abdolreza Hassanzadeh, et al.
Published: (2018-05-01) -
Arsenic trioxide induces expression of BCL-2 expression via NF-κB and p38 MAPK signaling pathways in BEAS-2B cells during apoptosis
by: Jing Tang, et al.
Published: (2021-10-01)